Mutations of SLC6A1 were reported in a variety of neurological and psychiatric disorders, myoclonic atonic epilepsy, intellectual disability (Johannesen et al., 2018, 1), autism (Wang et al., 2020), as well as schizophrenia (Rees et al., 2020). Here, SLC6A1 is linked to schizophrenia.